Third quarter revenue totaled $6.7 million
Commercial installed base increased by six systems to 29 RIO(R)
418 MAKOplasty(R) procedures performed, a 17% increase from second
Capital sales force size doubled to 16 sales people
$58.4 million equity financing completed
FORT LAUDERDALE, Fla., Nov. 3, 2009 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO – News), a medical device company that markets both its RIO(R) robotic arm interactive orthopedic surgical platform and proprietary RESTORIS(R) implants for minimally invasive orthopedic knee procedures known as MAKOplasty(R), today announced its operating results for the quarter ended September 30, 2009.
Recent Business Developments
RIO Systems – Six RIO systems were installed and customer accepted at commercial sites during the third quarter. These new sites brought the total number of MAKO’s commercial MAKOplasty sites to 29 as of September 30, 2009.
MAKOplasty Procedure Volume – During the third quarter, 418 MAKOplasty procedures were performed, representing a 17% increase over the second quarter of 2009 and a 163% increase over the third quarter of 2008. As of September 30, 2009, a total of 1,041 MAKOplasty procedures have been performed in 2009 and 1,823 procedures have been performed since the first procedure in June 2006.